Tsipi Ben-Kasus

Title: Tsipi Ben-Kasus: Innovator in Cancer Treatment

Introduction

Tsipi Ben-Kasus is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibody combinations. With a total of 2 patents, his work focuses on enhancing anti-tumor activity.

Latest Patents

One of Tsipi Ben-Kasus's latest patents involves a method for identifying a combination of antibodies that exhibit improved anti-tumor activity. This method includes identifying binding epitopes of anti ErbB-2 antibodies and selecting a combination of at least two antibodies that bind to different epitopes on the ErbB-2. Notably, at least one of these epitopes is localized to a dimerization site of the ErbB-2, which contributes to the combined improved anti-tumor activity. The patent also reveals novel antibody combinations uncovered through this research.

Career Highlights

Tsipi Ben-Kasus is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Throughout his career, Tsipi has collaborated with notable colleagues, including Michael Sela and Yosef Yarden. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

Tsipi Ben-Kasus stands out as a key figure in the field of cancer research, with his innovative approaches to antibody combinations paving the way for new treatment possibilities. His contributions are vital in the ongoing fight against cancer, and his work continues to inspire advancements in medical science.